None listed
Conditions
Brief summary
This study involves the testing and evaluation of a CVD medications intervention in a variety of primary care practices. It uses health literacy and adult education principles to help improve participants' knowledge of their medicines. The intervention involves participation in three sessions, facilitated by a trained staff member from the patients' enrolled primary care practice and guided by a digital application and a printed customised booklet. The medication information is tailored to each patient's prescribed medications. In this hybrid study, both implementation outcomes, including feasibility, acceptability, and scalability, will be assessed, as well as the effectiveness of the intervention in improving medication knowledge.
Interventions
The intervention is a three session medication knowledge program delivered by either a health coach, nurse or other trained health professional at the participants enrolled primary care practice. The first session will be undertaken at the primary care practice but there is an option for the second and third session to be completed online if that is more convienent for the participant. All facilitators will undertake both health literacy training and intervention specific training during a one d
The intervention is a three session medication knowledge program delivered by either a health coach, nurse or other trained health professional at the participants enrolled primary care practice. The first session will be undertaken at the primary care practice but there is an option for the second and third session to be completed online if that is more convienent for the participant. All facilitators will undertake both health literacy training and intervention specific training during a one day face to face session prior to the first patient being recruited. Each session will take 30-60- minutes depending on medications prescribed and the participants previous knowledge. The three sessions will be scheduled over 5-8 weeks. All sessions will be guided by a digital application which is customised to cover the participants prescribed CVD medications only and a customised booklet with more information that the participant can take home. During the first session the facilitator will confirm the CVD medications that the participant has been perscribed (via medical records) and enter the appropriate information into the digital application and the booklet, both which have been specifically designed for this intervention. Session attendance records and pre -post medication knowledge for each participant will be recorded by the facilitator during the session. Each primary care practice will recruit up to 25 participants and the medication knowledge intervention will be available for participants for seven months.
Sponsors
Martin Gagnon, The University of Otago
Study design
Allocation
Non-randomised trial
Primary purpose
Educational / counselling / training
Eligibility
Sex/Gender
All
Age
20 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Adults who are 20 years of age or older 2. enrolled with participating primary care practices, nurse practitioner clinics or long-term conditions or cardiac care programs. 3. been diagnosed with angina pectoris, myocardial infarction, transient ischemic attack, stroke, atrial fibrillation or heart failure AND are taking at least two of the following types of medicines: a. A statin b. Aspirin c. A beta blocker d. An ACE inhibitor. e. An ARNI f. An ARB g. A DOAC h. A SGLT2 inhibitor i. A diuretic
Exclusion criteria
1. Persons with cognitive deficit, such as receptive or expressive aphasia as indicated in the person’s medical record held by the practice, that interfere with the ability to participate in the intervention will not be eligible for the trial 2. Conditions which mean the person is unable to give informed consent for example intellectual disability
Outcome results
None listed